Delivery Order SPE2DB22D3301-SPE2DB25FZ0QM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $23,042.55 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 9, 2025, with an ultimate completion date of December 10, 2025. This non-competitive, firm fixed-price delivery order represents a single shipment of typhoid vaccine product for military or federal healthcare use. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates...
- The Defense Logistics Agency (DLA) awarded a $13,511.84 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price, non-set-aside contract represents a pediatric typhoid vaccine supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a delivery against...
- The Defense Logistics Agency awarded a $13,796.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order represents a single shipment of typhoid vaccine product to support federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,793.90, with a completion date of December 17, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of December 2, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $1,379.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, non-set-aside contract represents a small-value order for typhoid vaccine supplies to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,449 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with a completion date...
- The Defense Logistics Agency awarded a delivery order valued at $4,212.48 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (typhoid vaccine). This firm fixed-price, non-set-aside contract is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- The Defense Logistics Agency awarded a $1,931.44 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 mcg/0.5 mL syringes on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed price, non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a small-value transaction for a typhoid vaccine product, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical and medical...
- The Defense Logistics Agency awarded a $15,357.49 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. This competitively awarded, firm fixed-price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0QMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,241.97 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location and supply the typhoid vaccine product as part of its ongoing federal medical procurement obligations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including vaccines, specialty medications, and medical devices across multiple therapeutic domains. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles supporting military readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/5/25 |